Urine testing as a less invasive follow-up for early bladder cancer

Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

NIH-funded research Veterans Education/res/assn/north/ne · NIH-11142415

This project compares urine-based tests with routine cystoscopy for people being monitored after early-stage (non-muscle invasive) bladder cancer.

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionVeterans Education/res/assn/north/ne NIH-funded
Lab location1 site (White River Junction, United States)
Project IDNIH-11142415 on NIH RePORTER

What this research studies

If you join, researchers will use two urine tests (Xpert Bladder Cancer Monitor, an mRNA test, and Bladder EpiCheck, a DNA methylation test) to see if they can replace some routine cystoscopies. You would provide urine samples on a regular schedule while doctors track cancer recurrence and other outcomes over time. The team will compare how often the urine tests detect cancers and how often they give false positives that lead to additional procedures. The aim is to reduce uncomfortable cystoscopy visits while keeping cancer control the same.

Who could benefit from this research

Good fit: People with a history of non-muscle invasive bladder cancer who are undergoing routine surveillance after transurethral resection would be the ideal candidates.

Not a fit: Patients with muscle-invasive disease, those requiring immediate diagnostic cystoscopy, or newly diagnosed untreated tumors are unlikely to benefit from urine-only surveillance.

Why it matters

Potential benefit: If successful, this could reduce the number of invasive cystoscopies, lower discomfort and anxiety, and simplify long-term follow-up for bladder cancer survivors.

How similar studies have performed: Early studies show these urine tests have high sensitivity but only moderate specificity, so the approach is promising but not yet proven to safely replace cystoscopy.

Where this research is happening

White River Junction, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Bladder CancerCancer SurvivorCancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.